Babag, Arriane B.
HRN: 26-00-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
10/13/2024
10/17/2024
PO
5ml
BID
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes